EXJADE is not recommended in patients with severe hepatic impairment as it has not been studied in such patients.
EXJADE’ t ei soovitata kasutada raske maksakahjustusega patsientidel, kuna ravimi kasutamist nendel patsientidel ei ole uuritud.